HeLa and U-2OS cells were grown in Dulbecco’s modified Eagle medium (DMEM; Gibco, catalog no. 21063029), supplemented with 10% fetal bovine serum (FBS; Gibco, catalog no. 10438026), and 1% mL/L penicillin-streptomycin (Gibco, catalog no. 15140122) at 37 °C with 5% CO2. Cells were passaged twice to three times a week and used between passage number 2 and 20. Passaging was performed using 1× PBS and 0.05% Trypsin-EDTA (Gibco, catalog no. 25300054). Approximately 24 h before fixation, cells were seeded on fibronectin-coated glass coverslips at ~65,000 cells per well.
Copyright and License information: The Author(s) ©2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this
article to respond.